US · MANE
Veradermics, Incorporated
- Sector
- Healthcare · Biotechnology
- Headquarters
- New Haven, CT 06513
- Website
- veradermics.com
Price · as of 2026-07-02
$129.74
Market cap 4.03B
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| MANE | Veradermics, Incorporated | $129.74 | 4.03B | — | — | — | — | — | — | — | — | — |
| ABEO | Abeona Therapeutics Inc. | $5.78 | 329.43M | — | — | +68% | — | — | — | — | — | — |
| ADIL | Adial Pharmaceuticals, In… | $2.53 | 2.43M | — | — | — | — | -1.06 | 3.43 | — | -1.23 | — |
| DRMA | Dermata Therapeutics, Inc… | $1.35 | 920.1K | — | — | — | — | -0.15 | 1.19 | — | 0.11 | — |
| HELP | Cybin Inc. Common Stock | $4.49 | 224.02M | — | — | — | — | -2.22 | 1.06 | — | -0.82 | — |
| LSTA | Lisata Therapeutics, Inc. | $3.30 | 30.05M | — | — | — | +4,023% | — | — | — | — | — |
| OVID | Ovid Therapeutics Inc. | $2.64 | 348.17M | — | — | -78% | — | — | — | — | — | — |
| PLYX | Polaryx Therapeutics, Inc… | $3.05 | 144.4M | — | — | — | — | — | — | — | — | — |
| THAR | Tharimmune, Inc. | $3.54 | 139.94M | — | — | — | — | -0.16 | 1.51 | — | 0.13 | — |
| TVTX | Travere Therapeutics, Inc… | $47.76 | 4.44B | +18% | +14,934% | — | — | -103.12 | 22.94 | 5.37 | 118.84 | 11045.00% |
| XTLB | XTL Biopharmaceuticals Lt… | $2.46 | 5.82M | — | +773% | — | — | -2.05 | 0.39 | 4.66 | -1.18 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $129.74) − 1 = — (DCF, example).